Genedrive PLC
LSE:GDR
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
UK |
G
|
Genedrive PLC
LSE:GDR
|
2.9m GBP | 0 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
228.4B USD | 14.7 | ||
US |
Danaher Corp
NYSE:DHR
|
186.3B USD | 7.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
43.3B USD | 13 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.6B USD | 10.1 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.4B CHF | 15.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 30.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.2B USD | 14.7 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.1B USD | 23.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 11.7 | ||
US |
Waters Corp
NYSE:WAT
|
20.7B USD | 12.9 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.